BioCryst Pharmaceuticals, Inc. (BCRX) NASDAQ

7.70

+0.17(+2.26%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap1.55B
Enterprise Value2.29B
P/E Ratio-184.34
PEG Ratio-2.52
Price/Sales Ratio2.7
Price/Book Ratio-3.84
Enterprise/Revenue3.79
Enterprise/EBITDA27.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.01
Operating Margin0.13

Management Effectiveness

Return On Assets-0.02
Return On Equity0.02

Income Statement

Revenue450.71M
Revenue/Share2.85
Gross Profit438.23M
EBITDA12.81M
Net Income-88.88M
Diluted EPS-0.43

Balance Sheet

Total Cash212.87M
Total Cash/Share1.24
Total Debt683.11M
Total Debt/Equity-1.75
Current Ratio2.25
Book Value Per Share-2.01

Price History

52-Week Change0.39
52-Week High11.31
52-Week Low6
Moving Average 50 Days7.19
Moving Average 200 Days8.25

Statistics

Average Volume5.12M
Shares Outstanding210.56M
% Held by Institutions92.8

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A